Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MRK – Merck & Co., Inc.

Merck & Company, Inc.
MRK
$82.74
Name : Merck & Company, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $208,206,086,144.00
EPSttm : 6.88
finviz dynamic chart for MRK
Merck & Company, Inc.
$82.74
3.63%
$2.90

Float Short %

1.51

Margin Of Safety %

30

Put/Call OI Ratio

0.87525532735222

EPS Next Q Diff

0.39

EPS Last/This Y

1.29

EPS This/Next Y

0.87

Price

82.74

Target Price

109.63

Analyst Recom

1.85

Performance Q

-13.41

Relative Volume

1.57

Beta

0.46

Ticker: MRK




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-27MRK87.60.740.75638548
2025-03-28MRK89.230.810.42614754
2025-03-31MRK89.410.800.72599514
2025-04-01MRK87.120.801.77616230
2025-04-02MRK86.590.831.68637697
2025-04-03MRK86.370.842.20648891
2025-04-04MRK81.50.851.85656322
2025-04-07MRK81.180.891.96623078
2025-04-08MRK78.910.881.21641937
2025-04-09MRK81.880.881.25653599
2025-04-10MRK77.550.881.26660785
2025-04-11MRK79.110.850.89670526
2025-04-14MRK79.20.861.72655759
2025-04-15MRK78.450.872.31667278
2025-04-16MRK76.460.871.10682677
2025-04-17MRK77.960.850.56681208
2025-04-18MRK780.850.58681208
2025-04-21MRK77.580.920.63578417
2025-04-22MRK78.980.910.47595525
2025-04-23MRK78.70.900.61605240
2025-04-24MRK79.80.881.18632848
2025-04-25MRK82.740.875255327352220.33186746707618685794
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-27MRK87.592.56134.68.98
2025-03-28MRK89.232.56744.08.98
2025-03-31MRK89.762.56429.48.98
2025-04-01MRK87.123.05548.78.98
2025-04-02MRK86.603.66133.28.98
2025-04-03MRK86.393.66221.28.98
2025-04-04MRK81.463.04864.98.97
2025-04-07MRK81.203.35960.28.96
2025-04-08MRK78.953.55369.58.96
2025-04-09MRK81.853.56936.98.96
2025-04-10MRK77.532.94730.88.96
2025-04-11MRK79.103.06527.48.96
2025-04-14MRK79.173.06038.28.96
2025-04-15MRK78.392.65800.98.96
2025-04-16MRK76.442.65435.28.96
2025-04-17MRK78.002.66530.58.96
2025-04-18MRK78.002.66041.38.95
2025-04-21MRK77.873.56000.78.95
2025-04-22MRK78.973.56391.38.95
2025-04-23MRK78.743.45970.28.95
2025-04-24MRK79.853.16384.68.94
2025-04-25MRK82.743.16927.48.94
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-27MRK0.041.391.47
2025-03-28MRK0.041.391.47
2025-03-31MRK0.041.391.47
2025-04-01MRK0.041.391.47
2025-04-02MRK0.041.391.47
2025-04-03MRK0.041.391.47
2025-04-04MRK0.041.391.47
2025-04-07MRK0.041.401.47
2025-04-08MRK0.041.401.47
2025-04-09MRK0.041.401.47
2025-04-10MRK0.041.401.50
2025-04-11MRK0.041.401.50
2025-04-14MRK0.041.391.51
2025-04-15MRK0.041.391.51
2025-04-16MRK0.041.391.51
2025-04-17MRK0.041.391.51
2025-04-18MRK0.041.391.51
2025-04-21MRK0.041.391.51
2025-04-22MRK0.041.391.51
2025-04-23MRK0.041.391.51
2025-04-24MRK0.041.391.51
2025-04-25MRK0.041.391.51
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.72

Avg. EPS Est. Current Quarter

2.13

Avg. EPS Est. Next Quarter

2.11

Insider Transactions

0.04

Institutional Transactions

1.39

Beta

0.46

Average Sales Estimate Current Quarter

15585

Average Sales Estimate Next Quarter

15905

Fair Value

107.77

Quality Score

97

Growth Score

93

Sentiment Score

84

Actual DrawDown %

38.5

Max Drawdown 5-Year %

-41.1

Target Price

109.63

P/E

12.05

Forward P/E

8.45

PEG

0.99

P/S

3.27

P/B

4.52

P/Free Cash Flow

11.51

EPS

6.87

Average EPS Est. Cur. Y​

8.94

EPS Next Y. (Est.)

9.81

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

27.37

Relative Volume

1.57

Return on Equity vs Sector %

15.8

Return on Equity vs Industry %

7.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

6927.4
Merck & Company, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 73000
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
stock quote shares MRK – Merck & Co., Inc. Stock Price stock today
news today MRK – Merck & Co., Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MRK – Merck & Co., Inc. yahoo finance google finance
stock history MRK – Merck & Co., Inc. invest stock market
stock prices MRK premarket after hours
ticker MRK fair value insiders trading